Semax's pharmacokinetic profile is defined by a paradox: extremely short plasma half-life (minutes) yet prolonged CNS effects (hours to days)
It does not matter for B12 injections, which bypass the digestion process and directly enter the bloodstream
The CDC reports over seven billion injections annually across healthcare facilities
BPC-157: A Peptide with Remarkable Healing Potential In addition to the study discussed above, BPC-157 has been subject to numerous studies, and demonstrated promising therapeutic effects in different contexts, such as cellular aging, heart disturbances, spinal cord injuries, and major vessel occlusion disturbances
And impressive results that nearly match retatrutide, but at the price of tolerability for one of the doses
Listed on the WADA Prohibited List